FDA authorizes early access for experimental pancreatic cancer pill
- Posted on May 1, 2026
- By Washington Post
- 0 Views
- 1 min read
FDA authorizes early access for experimental pancreatic cancer pill
The FDA said the action recognizes the dire need for a drug to improve survival for pancreatic cancer patients, who face the worst survival odds in oncology.